
The companies will co-develop and co-commercialise bexobrutideg across malignant haematology, immunology and neurology

The new formulation would allow blood cancer patients to halve their daily pill intake

Approximately 6,500 new cases of the blood cancer are diagnosed in the UK each year

More than 35,000 people in the EU were diagnosed with the blood cancer in 2022

Up to 160,000 people in the US are affected by polycythaemia vera

Up to 70% of patients with this form of non-Hodgkin lymphoma are diagnosed with advanced disease

B-ALL is the most common form of the blood cancer, accounting for approximately 75% of adult cases

Approximately 500,000 people in the UK are affected by Crohn’s disease or ulcerative colitis

The findings could pave the way for new treatment approaches that improve patient outcomes

SIM0500 is in phase 1 development for patients with relapsed or refractory cases of the blood cancer

The research could pave the way for the development of new drugs that prevent drug resistance

More than 3,100 people are diagnosed with the aggressive blood cancer in the UK every year